Itrizole and platelet count decreased Patient Reports February 13, 2012

Itrizole Side Effects Report #5570636-3
Itrizole side effect was reported by a Physician from JAPAN on Dec 18, 2007. Male patient, 75 years of age, was diagnosed with systemic candida and was treated with Itrizole. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, multi-organ failure, platelet count decreased. Itrizole dosage: unknown. Patient died on 12/14/2007.

Itrizole Side Effects Report #5594428-4
Itrizole side effect was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma , purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.

Itrizole Side Effects Report #5605650-2
Itrizole side effect was reported by a Physician from JAPAN on Jan 21, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma , purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.

Itrizole Side Effects Report #5804741-0
Itrizole side effect was reported by a Physician from JAPAN on July 01, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, neutrophil count decreased, platelet count decreased, purpura, pyrexia, respiratory disorder, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.


Itrizole Side Effects Report #5946809-4
Itrizole side effect was reported by a Physician from JAPAN on Oct 27, 2008. Male patient, weighting 127.9 lb, was diagnosed with prophylaxis, multiple myeloma , benign prostatic hyperplasia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: chills, decreased appetite, ileus paralytic, neuropathy peripheral, platelet count decreased, pyrexia. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, THIAMINE DI SULPHIDE, VITAMIN B, GABAPENTIN, ASPARA K, EVIPROSTAT, OMEPRAL, COTRIM. Patient was hospitalized and became disabled. Patient recovered.

Itrizole Side Effects Report #5588110-7
Itrizole side effect was reported by a Physician from JAPAN on Dec 25, 2007. Male patient, weighting 116.8 lb, was diagnosed with pneumonia bacterial, multiple myeloma  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: inappropriate antidiuretic hormone secretion, interstitial lung disease, leukocytosis, orthostatic hypotension, platelet count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, DEXAMETHASONE. Patient recovered.

Itrizole Side Effects Report #5625676-2
Itrizole side effect was reported by a Physician from JAPAN on Feb 04, 2008. Male patient, weighting 116.8 lb, was diagnosed with pneumonia bacterial, multiple myeloma  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: condition aggravated, inappropriate antidiuretic hormone secretion, interstitial lung disease, leukocytosis, multiple myeloma , orthostatic hypotension, platelet count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, DEXAMETHASONE. Patient recovered.

Itrizole Side Effects Report #4774422-3
Itrizole side effect was reported by a Physician from JAPAN on Sept 12, 2005. Male patient, 68 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: platelet count decreased, pyrexia, toxic skin eruption. Itrizole dosage: unknown. Patient was hospitalized. Patient recovered.

Itrizole Side Effects Report #4791027-9
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Male patient, 68 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: platelet count decreased, pyrexia, toxic skin eruption. Itrizole dosage: unknown. Patient was hospitalized. Patient recovered.


Itrizole Side Effects Report #5524571-7
Itrizole side effect was reported by a Pharmacist from JAPAN on Nov 13, 2007. Female patient, 76 years of age, was treated with Itrizole. After drug was administered, patient experienced the following side effects: cardiac failure, electrocardiogram pq interval prolonged, platelet count decreased. Itrizole dosage: unknown. During the same period patient was treated with VITANEURIN, SELBEX, BONALON. Patient recovered.

Itrizole Side Effects Report #5105585-8
Itrizole side effect was reported by a Physician from JAPAN on Sept 06, 2006. Female patient, 61 years of age, was diagnosed with nail tinea, hyperlipidaemia, hypertension and was treated with Itrizole. After drug was administered, patient experienced the following side effects: gingival bleeding, liver function test abnormal, platelet count decreased. Itrizole dosage: unknown. During the same period patient was treated with MEVALOTIN, MAINTATE, NORVASC, BAYASPIRIN. Patient was hospitalized. Patient recovered.

Itrizole Side Effects Report #4710468-9
Itrizole side effect was reported by a Physician from JAPAN on June 28, 2005. Female patient, 56 years of age, was diagnosed with onychomycosis, spinal column stenosis, osteoporosis  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: platelet count decreased. Itrizole dosage: unknown. During the same period patient was treated with LIMAPROST ALFADEX, LORNOXICAM, SOFALCONE, ALENDRONATE, THEOPHYLLINE, KETOTIFEN FUMARATE. Patient recovered.

Itrizole Side Effects Report #4735712-3
Itrizole side effect was reported by a Physician from JAPAN on July 25, 2005. Female patient, 56 years of age, was diagnosed with onychomycosis, spinal column stenosis, osteoporosis  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: platelet count decreased. Itrizole dosage: unknown. During the same period patient was treated with LIMAPROST ALFADEX, LORNOXICAM, SOFALCONE, ALENDRONATE, THEOPHYLLINE, KETOTIFEN FUMARATE. Patient recovered.

Itrizole Side Effects Report #4751617-6
Itrizole side effect was reported by a Physician from JAPAN on Aug 15, 2005. Female patient, 56 years of age, was diagnosed with onychomycosis, spinal column stenosis, osteoporosis  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: oculomucocutaneous syndrome, platelet count decreased. Itrizole dosage: unknown. During the same period patient was treated with LIMAPROST ALFADEX, LORNOXICAM, SOFALCONE, ALENDRONATE, THEOPHYLLINE, KETOTIFEN FUMARATE. Patient recovered.


Itrizole Side Effects Report #5636850-3
Itrizole side effect was reported by a Pharmacist from JAPAN on Feb 15, 2008. Female patient, weighting 70.55 lb, was diagnosed with bronchopulmonary aspergillosis, hypertension, anxiety , reflux oesophagitis, gastritis, osteoporosis  and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood pressure increased, cardiac failure, electrocardiogram qt prolonged, headache , platelet count decreased, stomach discomfort. Itrizole dosage: unknown. During the same period patient was treated with VITANEURIN, SELBEX, BONALON. Patient recovered.